Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03271099 · ClinicalTrials.gov registry record · NA

Patient Navigation in Cancer Survivorship at a Safety Net Institution

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT03271099 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03271099, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.

Interventions

  • OTHER Navigator

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-10-16
Est. Completion 2020-09-10
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT03271099

The ClinicalTrials.gov registry entry for NCT03271099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Navigator is the first listed.

NCT03271099 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03271099 about?

NCT03271099 is a clinical study titled "Patient Navigation in Cancer Survivorship at a Safety Net Institution". This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.

What is the current status of trial NCT03271099?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-10-16. Estimated completion is 2020-09-10.

What interventions are being tested in trial NCT03271099?

The interventions under investigation include: Navigator (OTHER).

Who is sponsoring clinical trial NCT03271099?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.